1999
DOI: 10.1007/bf03038893
|View full text |Cite
|
Sign up to set email alerts
|

Proton therapy for uveal melanomas and other eye lesions

Abstract: Charged particle beams are ideal for treating intra-ocular lesions, since they can be made to deposit their dose in the target, while significantly limiting dose received by non-involved ocular and orbital structures. Proton beam treatment of large numbers of uveal melanoma patients consistently achieves local control rates in excess of 95%, and eye retention rates of approximately 90%. Visual preservation is related to initial visual acuity, tumor size and location, and dose received by the macula, disc, and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(18 citation statements)
references
References 48 publications
0
18
0
Order By: Relevance
“…As of December 2002, over 3000 patients with uveal melanoma had been treated with protons at the MGH in collaboration with MEEI (Munzenrider, 1999). The 5-year actuarial local control rate Figure 1 Depth -dose distributions for a spread-out Bragg peak (SOBP, red), its constituent pristine Bragg peaks (blue), and a 10 MV photon beam (black).…”
Section: Ocular (Uveal) Melanomamentioning
confidence: 99%
“…As of December 2002, over 3000 patients with uveal melanoma had been treated with protons at the MGH in collaboration with MEEI (Munzenrider, 1999). The 5-year actuarial local control rate Figure 1 Depth -dose distributions for a spread-out Bragg peak (SOBP, red), its constituent pristine Bragg peaks (blue), and a 10 MV photon beam (black).…”
Section: Ocular (Uveal) Melanomamentioning
confidence: 99%
“…A metal bead that was used to simulate a tumor can be clearly identified in the bottom right image secondary glaucoma. Other options are available along with the development of radiotherapy, including plaque brachytherapy [16,28], proton radiotherapy [23], transpupillary thermotherapy [24], and the promising stereotactic radiotherapy [2,18,21]. Taking the advantages of non-invasive treatment, Cyberknife radiosurgery has become an effective alternative for uveal melanoma.…”
Section: Discussionmentioning
confidence: 99%
“…The Massachussets General Hospital/Harvard Cyclotron Laboratory (MGH/HCL) in Boston played a pioneering role, and 2568 uveal melanoma patients were treated through September 1998 [17].…”
Section: Uveal Melanomamentioning
confidence: 99%